LAURIE TREASTER: Open Payments
NPI 1144268970 · LEWISBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$958 in 56 payments from 12 companies in 2025. Trend: 2023 $1,267 · 2024 $1,019 · 2025 $958
Food & beverage: $958
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $213 |
| ABBVIE INC. | 11 | $172 |
| PFIZER INC. | 5 | $95 |
| Amgen Inc. | 6 | $91 |
| Exact Sciences Corporation | 4 | $86 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $78 |
| AstraZeneca Pharmaceuticals LP | 5 | $75 |
| GlaxoSmithKline, LLC. | 3 | $54 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34 |
| Phathom Pharmaceuticals, Inc. | 2 | $34 |
Products named: VRAYLAR, Wegovy, Cologuard Collection Kit, CAPLYTA, Ozempic, EVENITY, ELIQUIS, PAXLOVID.
Industry payments across PA — which companies pay providers there.
